Search - tctmd.com

Displaying 241 - 260 of 8219

Sort: Relevancy | Date

Presentation TCT 2016

Hot Topic #1: Implications of the SPRINT Trial on the Target for Blood Pressure Control

Presenter: Bernard J. Gersh, Felix Mahfoud

November 01, 2016

Presentation TCT 2016

Neuromodulation for the Treatment of Resistant Hypertension: First-In-Human Evaluation of an Implanted Median Nerve Stimulator

Presenter: Emerson C. Perin, Mark W.I. Webster

November 01, 2016

Presentation TCT 2016

Featured Lecture: Balancing the Needs for Data Transparency and the Clinical Trial Enterprise

Presenter: Robert O. Bonow, Mitchell W. Krucoff, Manesh R. Patel

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

News Conference News TCT 2016

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Todd Neale

November 01, 2016

Presentation TCT 2016

The First Clinical Experience with a Novel Directional Coronary Atherectomy Catheter

Presenter: Fernando Alfonso, Ran Kornowski, Maoto Habara

November 01, 2016

Presentation TCT 2016

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up

Presenter: Fernando Alfonso, Ran Kornowski, Pieter R. Stella

November 01, 2016

Presentation TCT 2016

My Worst Nightmare Case I Learned From: Case #4

Presenter: M.S. Hiremath, Narenda N. Khanna, Kamal K. Sethi, Sundeep Mishra

November 01, 2016

Presentation TCT 2016

My Worst Nightmare Case I Learned From: Case #2

Presenter: M.S. Hiremath, Narenda N. Khanna, Kamal K. Sethi

November 01, 2016

Presentation TCT 2016

My Worst Nightmare Case I Learned From: Case #1

Presenter: M.S. Hiremath, Narenda N. Khanna, Kamal K. Sethi, Amal Kumar Banerjee

November 01, 2016

Presentation TCT 2016

My Most Rewarding Case: Case #3

Presenter: M.S. Hiremath, Narenda N. Khanna, Kamal K. Sethi, Rabin dra Nath Chakraborty

November 01, 2016

Presentation TCT 2016

My Most Rewarding Case: Case #2

Presenter: M.S. Hiremath, Narenda N. Khanna, Kamal K. Sethi, Jamshed J. Dalal

November 01, 2016

Presentation TCT 2016

My Most Rewarding Case: Case #1

Presenter: M.S. Hiremath, Narenda N. Khanna, Kamal K. Sethi, Sreenivas Arramraju Kumar

November 01, 2016

News Industry News

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

November 01, 2016

News Industry News

Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients

November 01, 2016

Presentation TCT 2016

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, Pamela S. Douglas

November 01, 2016

News Industry News TCT 2016

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

November 01, 2016

Presentation TCT 2016

Takayasus Arteritis: Lessons From a Large Interventional

Presenter: Vinay K. Bahl, Amal Kumar Banerjee, Narenda N. Khanna

November 01, 2016

Presentation TCT 2016

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen

November 01, 2016

Presentation TCT 2016

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Gregg W. Stone, Philippe Pibarot, Susheel K. Kodali

November 01, 2016

Advertisement

Hot Topic #1: Implications of the SPRINT Trial on the Target for Blood Pressure Control

Neuromodulation for the Treatment of Resistant Hypertension: First-In-Human Evaluation of an Implanted Median Nerve Stimulator

Featured Lecture: Balancing the Needs for Data Transparency and the Clinical Trial Enterprise

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

The First Clinical Experience with a Novel Directional Coronary Atherectomy Catheter

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up

My Worst Nightmare Case I Learned From: Case #4

My Worst Nightmare Case I Learned From: Case #2

My Worst Nightmare Case I Learned From: Case #1

My Most Rewarding Case: Case #3

My Most Rewarding Case: Case #2

My Most Rewarding Case: Case #1

Study Finds Use Of Adjuctive Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Was Safe But Improvement In MRI Findings Did Not Reach Statistical Significance

Five Year Echocardiogram Follow-Up Data Demonstrates Sustained Durability After Transcatheter Aortic Valve Replacement In High-Risk And Inoperable Patients

PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis

Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement

Takayasus Arteritis: Lessons From a Large Interventional

PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

SENTINEL: A Prospective, Randomized Trial Evaluating Cerebral Protection in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content